Journal News

From the journals: JLR

Vaishnavi Muralikrishnan
May 27, 2021

Why is a high level of HDL cholesterol not always a good thing? How does gut bacteria assimilate dietary lipids? How can researchers measure pleiotropic genetic risk factors? Read about recent papers in the Journal of Lipid Research that address these questions.

Why high HDL is not always good

Heart diseases are the leading cause of death in the U.S. Coronary heart disorder, the most common type of heart disease, is caused by atherosclerosis, or the accumulation of cholesterol in the arterial walls leading to stiffening and lowered blood flow in the arteries. The two types of cholesterol are low-density lipoprotein, or LDL, and high-density lipoprotein, or HDL. While HDL cholesterol often is referred to as "good cholesterol" because of the inverse correlation between HDL levels and heart disorders, presence of excess HDL in plasma may be due to reduced plasma clearance of cholesterol.

Atherosclerosis-445x334.jpg
NIH/FLICKR
This illustration shows a normal artery on the left and narrowing of the artery due to deposit of cholesterol plaque on the right, which represents atherosclerosis.

The primary receptor for HDL is scavenger receptor class B type I, or SR-BI, which promotes clearance of excess cholesterol from the plasma, thus reducing the risk for atherosclerosis.

In a recent study in the Journal of Lipid Research, Sarah C. May and her colleagues at the Medical College of Wisconsin characterized a rare heterozygous variant of the gene encoding SR-BI that results in the substitution of arginine-174 with cysteine, or R174C, in a patient with high HDL cholesterol levels. They demonstrated that the R174C mutation leads to diminished cholesterol transport, suggesting this variant does not clear cholesterol from circulation as intended.

The researchers write that the reduced function of this variant could be due to disruptions in surface electrostatic charges of SR-BI leading to a decrease in the net-positive charge, which in turn could affect the ability of SR-BI to bind HDL and transport cholesterol from HDL particles.

This study provides an insight into the structure and function of SR-BI and emphasizes that measurement of HDL-cholesterol levels may not be a sufficient indicator to predict the risk of cardiovascular diseases accurately.

 

How gut bacteria assimilate dietary lipids

The human intestine is home to trillions of microorganisms known collectively as the gut microbiota. The type and amount of fat we eat can have a significant impact on the gut microbiome and thus on our metabolism and immunity. Sphingolipids are a class of bioactive lipids present in foods such as milk and also produced by gut microbes. However, researchers do not understand yet how the gut microbes use sphingolipids.

 

Recent research by Min-Ting Lee and colleagues at Cornell University published in the Journal of Lipid Research used a novel technique called Bioorthogonal labeling-Sort-Seq-Spec, or BOSSS, to study the assimilation of sphingolipids by gut microbes. The first step in BOSSS, bioorthogonal labeling of sphingolipids, involved labeling without interfering with native biochemical processes in the body. The next step was fluorescence-based sorting of microbes containing the labeled sphingolipids. Finally, the sorted microbes were sequenced and analyzed by mass spectrometry to identify products of sphingolipid assimilation.

The researchers found that sphingolipids are assimilated primarily by a type of gut microbes known as Bacteriodes. This improves our understanding of how dietary sphinganine is processed in the body and how it in turn affects the gut microbiome. In addition, the novel BOSSS technique is useful to study the flux of any alkyne-labeled metabolite in diet–microbiome interactions.

 

A randomization to measure risk

Variations in certain genes can act as risk factors for some diseases, and these risk associations can be studied using a technique called Mendelian randomization, or MR. This technique measures variations in genes whose functions are known in order to determine whether the variations can cause specific diseases in humans.

In a recent study in the Journal of Lipid Research, David G. Thomas and colleagues at Columbia University performed an MR of lipid traits such as levels of low-density lipoprotein, high-density lipoprotein, triglycerides, body mass index, Type 2 diabetes and systolic blood pressure in coronary artery disease, or CAD, in large genomewide association study data sets.

A challenging aspect of determining the effect of risk factors is that some of these lipid trait variants may be pleiotropic, meaning that a single gene can influence two or more seemingly unrelated phenotypic traits. This study used multivariate MR analysis to evaluate the pleiotropic effects of lipid trait genetic variants and to adjust for these effects in evaluating the risk for CAD. The researchers reported that the lipid traits they studied all are associated independently with CAD even after adjusting for their pleiotropic effects.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Vaishnavi Muralikrishnan

Vaishnavi Muralikrishnan is a Ph.D. candidate at Indiana University. She studies ovarian cancer stem cells in the laboratory of Kenneth Nephew. She is passionate about science communication and enjoys her naps and drinking chai.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

E-cigarettes drive irreversible lung damage via free radicals
Journal News

E-cigarettes drive irreversible lung damage via free radicals

April 17, 2025

E-cigarettes are often thought to be safer because they lack many of the carcinogens found in tobacco cigarettes. However, scientists recently found that exposure to e-cigarette vapor can cause severe, irreversible lung damage.

Using DNA barcodes to capture local biodiversity
ASBMB Annual Meeting

Using DNA barcodes to capture local biodiversity

April 15, 2025

Undergraduate at the University of California, Santa Barbara, leads citizen science initiative to engage the public in DNA barcoding to catalog local biodiversity, fostering community involvement in science.

Targeting Toxoplasma parasites and their protein accomplices
Journal News

Targeting Toxoplasma parasites and their protein accomplices

April 11, 2025

Researchers identify that a Toxoplasma gondii enzyme drives parasite's survival. Read more about this recent study from the Journal of Lipid Research.

Scavenger protein receptor aids the transport of lipoproteins
Journal News

Scavenger protein receptor aids the transport of lipoproteins

April 11, 2025

Scientists elucidated how two major splice variants of scavenger receptors affect cellular localization in endothelial cells. Read more about this recent study from the Journal of Lipid Research.

Fat cells are a culprit in osteoporosis
Journal News

Fat cells are a culprit in osteoporosis

April 11, 2025

Scientists reveal that lipid transfer from bone marrow adipocytes to osteoblasts impairs bone formation by downregulating osteogenic proteins and inducing ferroptosis. Read more about this recent study from the Journal of Lipid Research.

Unraveling oncogenesis: What makes cancer tick?
ASBMB Annual Meeting

Unraveling oncogenesis: What makes cancer tick?

April 7, 2025

Learn about the ASBMB 2025 symposium on oncogenic hubs: chromatin regulatory and transcriptional complexes in cancer.